[Identification of filamentous fungi isolated from clinical samples by two different methods and their susceptibility

Sahin Direkel1, Feza Otağ, Gönül Aslan

  • 1Mersin University Faculty of Medicine, Department of Medical Microbiology, Mersin, Turkey. sdirekel@yahoo.com

Mikrobiyoloji Bulteni
|March 9, 2012
PubMed

Insights

This study identified filamentous fungi in clinical samples using conventional and molecular methods, finding that Aspergillus and Fusarium species are common. Accurate identification and antifungal susceptibility testing are crucial for managing invasive fungal infections in immunocompromised patients.

Area of Science:

  • Medical Mycology
  • Clinical Microbiology

Context:

  • Molds, particularly Aspergillus spp., are significant causes of morbidity and mortality in immunocompromised individuals.
  • Accurate identification and antifungal susceptibility of filamentous fungi are critical for effective treatment.

Purpose:

  • To identify filamentous fungi from clinical specimens using conventional and molecular methods.
  • To determine the antifungal susceptibilities of isolated filamentous fungi.

Summary:

  • A total of 6742 clinical specimens were analyzed, yielding 71 isolates of filamentous fungi from 32 patients.
  • Conventional and DNA sequencing methods were used for identification, with DNA sequencing resolving discrepancies in three isolates.
  • Antifungal susceptibility testing included fluconazole, voriconazole, amphotericin B, caspofungin, and posaconazole, revealing varying resistance patterns.

Impact:

  • Conventional methods provide reliable identification of common filamentous fungi like Aspergillus and Fusarium.
  • The study highlights the increasing rate of invasive fungal infections, emphasizing the need for prompt diagnosis in at-risk populations.
  • Accurate identification and susceptibility data can guide treatment strategies and reduce mortality associated with invasive mold infections.